To Establish Whether Dapagliflozin and Spironolactone in Patients With Severe Aortic Stenosis Undergoing Aortic Valve Replacement, Result in Better Left Ventricular Mass Regression, Myocardial Health and Patient Reported Outcomes
Not yet recruitingNCT07539259
University College, LondonAortic Stenosis
Start: 2026-12-01End: 2030-02-28Target: 445Updated: 2026-05-18